Skip to content

Insider · CIK 0001820961

Lance Kurata

officer

Files at ARCT (Arcturus Therapeutics Holdings Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 17, 2025ARCT
Arcturus Therapeutics Holdings Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+54,000$0.00$054,000Dec 19, 2025
Dec 16, 2024ARCT
Arcturus Therapeutics Holdings Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+60,000$0.00$060,000Dec 18, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Lance Kurata: insider trades and track record | InsiderTell